See All Slides - tctmd.com

Slides

Presentation TCT 2013

How to Get Started

Presenter: Adhir Shroff

October 28, 2013

Presentation TCT 2013

The Hybrid Approach IV: When to go Retrograde and to Select Septals

Presenter: Julian Strange

October 28, 2013

Presentation TCT 2013

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Presenter: Bruce Samuels

October 28, 2013

Presentation TCT 2013

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Presenter: Blase Carabello

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

Case Vignettes in Provisional Left Main Stenting: A 2nd Stent Became Necessary

Presenter: Nicholas Lembo

October 28, 2013

Presentation TCT 2013

The CTO PCI Learning Curve (And Ancillary Benefits for non-CTO PCI Outcomes)

Presenter: Dimitri Karmpaliotis

October 28, 2013

Presentation TCT 2013

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Presenter: Raj Makkar

October 28, 2013

Advertisement

Slides

How to Get Started

The Hybrid Approach IV: When to go Retrograde and to Select Septals

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Case Vignettes in Provisional Left Main Stenting: A 2nd Stent Became Necessary

The CTO PCI Learning Curve (And Ancillary Benefits for non-CTO PCI Outcomes)

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content